{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:09:05Z","timestamp":1787990945428,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme Corp.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Merck & Co., Inc., Kenilworth, NJ, USA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijid.2020.10.017","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:44:18Z","timestamp":1602596658000},"page":"260-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan"],"prefix":"10.1016","volume":"102","author":[{"given":"Katsunori","family":"Yanagihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kosai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Takesue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4465-6656","authenticated-orcid":false,"given":"Machiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaz","family":"Petigara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.ijid.2020.10.017_bib0005","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.vaccine.2016.07.003","article-title":"Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults","volume":"34","author":"Baxter","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ijid.2020.10.017_bib0010","doi-asserted-by":"crossref","first-page":"e0175224","DOI":"10.1371\/journal.pone.0175224","article-title":"Decrease of invasive pneumococcal disease (IPD) in adults after introduction of pneumococcal 13-valent conjugate vaccine in Spain","volume":"12","author":"C\u00e0mara","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2020.10.017_bib0015","unstructured":"Centers for Disease Control and Prevention. Pneumonia. https:\/\/www.cdc.gov\/nchs\/fastats\/pneumonia.htm, 2018 (accessed 23 September 2020)."},{"key":"10.1016\/j.ijid.2020.10.017_bib0020","series-title":"M100-S27: Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2017"},{"issue":"1","key":"10.1016\/j.ijid.2020.10.017_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12879-016-2113-y","article-title":"Invasive pneumococcal disease among adults in Japan, April 2013 to March 2015: disease characteristics and serotype distribution","volume":"17","author":"Fukusumi","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.10.017_bib0030","doi-asserted-by":"crossref","first-page":"e0147877","DOI":"10.1371\/journal.pone.0147877","article-title":"Invasive Pneumococcal Diseases Surveillance Study Group. Host factors and biomarkers associated with poor outcomes in adults with invasive pneumococcal disease","volume":"11","author":"Hanada","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijid.2020.10.017_bib0035","doi-asserted-by":"crossref","first-page":"e018553","DOI":"10.1136\/bmjopen-2017-018553","article-title":"Risk of pneumococcal diseases in adults with underlying medical conditions: a retrospective, cohort study using two Japanese healthcare databases","volume":"8","author":"Imai","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ijid.2020.10.017_bib0040","first-page":"1","article-title":"JAID\/JSC treatment guideline for infectious diseases","volume":"62","author":"Japan Association of Infectious Disease and Japan Society of Chemotherapy","year":"2014","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.ijid.2020.10.017_bib0045","first-page":"183","article-title":"Report of the Committee for Antimicrobial Susceptibility Testing: method for the determination of minimum inhibitory concentration (MIC) of aerobic bacteria by microdilution method","volume":"41","author":"Japan Society of Chemotherapy","year":"1993","journal-title":"Chemotherapy (Tokyo)"},{"key":"10.1016\/j.ijid.2020.10.017_bib0050","unstructured":"Japanese Respiratory Society. The JRS Guidelines for the management of community-acquired pneumonia in adults [In Japanese]. https:\/\/www.jrs.or.jp\/modules\/guidelines\/index.php?content_id=15, 2018 (accessed 23 September 2020)"},{"issue":"4","key":"10.1016\/j.ijid.2020.10.017_bib0055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2020.10.017_bib0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.ijid.2020.10.017_bib0065","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"123","key":"10.1016\/j.ijid.2020.10.017_bib0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1183\/09059180.00008911","article-title":"The remaining challenges of pneumococcal disease in adults","volume":"21","author":"Ludwig","year":"2012","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.ijid.2020.10.017_bib0075","unstructured":"Ministry of Health, Labour and Welfare. Statistics for vaccination rate [In Japanese]. https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html, 2019 (accessed 23 September 2020)."},{"issue":"7","key":"10.1016\/j.ijid.2020.10.017_bib0080","doi-asserted-by":"crossref","first-page":"e030197","DOI":"10.1136\/bmjopen-2019-030197","article-title":"Factors associated with PPSV23 coverage among older adults in Japan: a nationwide community-based survey","volume":"9","author":"Murakami","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.ijid.2020.10.017_bib0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jiph.2019.05.019","article-title":"Assessment of the local clonal spread of Streptococcus pneumoniae serotype 12F caused invasive pneumococcal diseases among children and adults","volume":"12","author":"Nakanishi","year":"2019","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijid.2020.10.017_bib0090","first-page":"107","article-title":"Pneumococcal infections in 2017, Japan","volume":"39","author":"National Institute of Infectious Diseases","year":"2018","journal-title":"Infect Agent Surveillance Report"},{"issue":"9","key":"10.1016\/j.ijid.2020.10.017_bib0095","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1099\/jmm.0.001047","article-title":"Clonal spread of serotype 12F ST4846 Streptococcus pneumoniae","volume":"68","author":"Ohkusu","year":"2019","journal-title":"J Med Microbiol"},{"issue":"24","key":"10.1016\/j.ijid.2020.10.017_bib0100","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.vaccine.2009.03.017","article-title":"Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics","volume":"27","author":"Poolman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2020.10.017_bib0105","unstructured":"Public Health England. Pneumococcal polysaccharide vaccine (PPV) coverage report, England, April 2018 to March 2019. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/847408\/hpr3919_PPV.pdf (accessed 23 September 2020)."},{"issue":"3","key":"10.1016\/j.ijid.2020.10.017_bib0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3201\/eid2403.170769","article-title":"Emergence of Streptococcus pneumoniae serotype 12F after sequential introduction of 7- and 13-valent vaccines, Israel","volume":"24","author":"Rokney","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.ijid.2020.10.017_bib0115","doi-asserted-by":"crossref","first-page":"e1001903","DOI":"10.1371\/journal.pmed.1001903","article-title":"The PneuCarriage Project: A multi-centre comparative study to identify the best serotyping methods for examining pneumococcal carriage in vaccine evaluation studies","volume":"12","author":"Satzke","year":"2015","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.ijid.2020.10.017_bib0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/civ803","article-title":"Invasive pneumococcal disease among immunocompromised persons: implications for vaccination programs","volume":"62","author":"Shigayeva","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.10.017_bib0125","doi-asserted-by":"crossref","first-page":"e0212418","DOI":"10.1371\/journal.pone.0212418","article-title":"Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan","volume":"14","author":"Shimbashi","year":"2019","journal-title":"PLoS One"},{"issue":"45","key":"10.1016\/j.ijid.2020.10.017_bib0130","doi-asserted-by":"crossref","first-page":"6054","DOI":"10.1016\/j.vaccine.2015.07.069","article-title":"Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine","volume":"33","author":"Suga","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ijid.2020.10.017_bib0135","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3201\/eid2111.142029","article-title":"Serotype changes and drug resistance in invasive pneumococcal diseases in adults after vaccinations in children, Japan, 2010-2013","volume":"21","author":"Ubukata","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijid.2020.10.017_bib0140","unstructured":"Ubukata K, Iwata S, Ishii M, Hanada S. Pneumococcal infectious diseases and vaccine \u2013 Think Globally, Act Locally; March 1, 2019. http:\/\/spn-vac.umin.jp\/en\/index.html (accessed 23 September 2020)."},{"key":"10.1016\/j.ijid.2020.10.017_bib0145","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid2411.180326","article-title":"Effects of pneumococcal conjugate vaccine on genotypic penicillin resistance and serotype changes, Japan, 2010\u20132017","volume":"24","author":"Ubukata","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2020.10.017_bib0150","doi-asserted-by":"crossref","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ijid.2020.10.017_bib0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1473-3099(19)30292-0","article-title":"Novel insights into pneumococcal lineages in the vaccine era","volume":"19","author":"Varon","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2020.10.017_bib0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jiac.2019.05.006","volume":"25","author":"Yanagihara","year":"2019","journal-title":"J Infect Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220322220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220322220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:58:08Z","timestamp":1761119888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220322220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":32,"alternative-id":["S1201971220322220"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.017","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}